Zurueck zur Suche

Reporte zur Charge 554NM

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

12Reporte angezeigt
0Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
1Bleibende Schaeden
CA 2 RI 2 CO 2 GA 2 AR 1 NV 1 IN 1 NC 1

VAERS 2721059

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

schwer
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
05.12.2023
Impfdatum
19.10.2023
Beginn
22.10.2023
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Computerised tomogram spine Guillain-Barre syndrome Intervertebral disc degeneration Intervertebral disc protrusion Intervertebral disc space narrowing Ligamentum flavum hypertrophy Magnetic resonance imaging spinal abnormal Radiculopathy Scan with contrast abnormal Scoliosis Spinal flattening Vertebral foraminal stenosis Vertebral lateral recess stenosis Wheelchair user

Symptomtext

Pt was hospitalized for GBS with prolonged hospitalization at hospital and rehab hopsital. Now currently in a wheelchair

Weitere VAERSDATA-Felder
Praegender Schweregrund
Guillain-Barre syndrome
Hospital-Tage
5,0
Labordaten
MRI Lumbar Spine w wo Contrast Anatomical Region Laterality Modality L-spine ? Magnetic Resonance Spine ? ? Impression IMPRESSION: Mild nerve root enhancement as above suggesting neuritis. Mild multilevel degenerative disc, endplate and facet changes with generally mild degrees of neural comprise, moderate on the left at L5-S1. Electronically signed by: 10/23/2023 5:01 PM Narrative MRI LUMBOSACRAL SPINE WITH AND WITHOUT CONTRAST EXAMINATION DATE AND TIME: 10/23/2023 2:28 PM HISTORY: Demyelinating disease COMPARISON: Cervical and thoracic MRI reported separately. Previous day CT lumbar. TECHNIQUE: The following images were obtained on a Phillips 1.5 Tesla high field MRI scanner. Sagittal T1 STIR and T2 weighted images. Axial T1 and T2-weighted images. Sagittal fat-suppressed T1-weighted post gadolinium images. Axial postgadolinium T1-weighted images 8 cc of Gadavist was utilized DISCUSSION: There is mild lumbar levoscoliosis and loss of the normal lumbar lordosis, without fracture, wedge deformity, spondylolysis or spondylolisthesis. There are considerable L4-5 and L5-S1 degenerative endplate marrow changes without a marrow or soft tissue edema pattern to suggest fracture or bone destruction. There is mild heterogeneous marrow signal consistent with red marrow conversion, without destructive bone lesion. The conus terminates at L1 without conus signal abnormalities. There is mild nerve root enhancement in the anterior aspect of the cauda equina starting at the L1 level, with slightly increased bilateral nerve root enhancement of the L3, L4, L5, S1 and S2 descending nerve roots, question mild neuritis. T12-L1, L1-2 and L2-3 demonstrate normal discs, endplates and facets. L3-4 demonstrates slight disc bulge without narrowing or desiccation. There is mild ligament hypertrophy. There is slight dural impression and nominal foraminal narrowing without significant neural compromise. L4-5 demonstrates disc desiccation with degenerative endplate marrow change and 2 to 3 mm disc bulge. There is mild facet degeneration and ligament prominence. There is nominal dural impression including nominal inferior foraminal narrowing, without focal neural compression. L5-S1 demonstrates disc desiccation and slight narrowing with 3 to 4 mm right greater than left disc bulge. There is mild facet degeneration. There is moderate left and minimal right lateral recess stenosis with mild right and minimal left foraminal stenosis, without spinal stenosis. Procedure Note MD - 10/23/2023 Formatting of this note might be different from the original. MRI LUMBOSACRAL SPINE WITH AND WITHOUT CONTRAST EXAMINATION DATE AND TIME: 10/23/2023 2:28 PM HISTORY: Demyelinating disease COMPARISON: Cervical and thoracic MRI reported separately. Previous day CT lumbar. TECHNIQUE: The following images were obtained on a Phillips 1.5 Tesla high field MRI scanner. Sagittal T1 STIR and T2 weighted images. Axial T1 and T2-weighted images. Sagittal fat-suppressed T1-weighted post gadolinium images. Axial postgadolinium T1-weighted images 8 cc of Gadavist was utilized DISCUSSION: There is mild lumbar levoscoliosis and loss of the normal lumbar lordosis, without fracture, wedge deformity, spondylolysis or spondylolisthesis. There are considerable L4-5 and L5-S1 degenerative endplate marrow changes without a marrow or soft tissue edema pattern to suggest fracture or bone destruction. There is mild heterogeneous marrow signal consistent with red marrow conversion, without destructive bone lesion. The conus terminates at L1 without conus signal abnormalities. There is mild nerve root enhancement in the anterior aspect of the cauda equina starting at the L1 level, with slightly increased bilateral nerve root enhancement of the L3, L4, L5, S1 and S2 descending nerve roots, question mild neuritis. T12-L1, L1-2 and L2-3 demonstrate normal discs, endplates and facets. L3-4 demonstrates slight disc bulge without narrowing or desiccation. There is mild ligament hypertrophy. There is slight dural impression and nominal foraminal narrowing without significant neural compromise. L4-5 demonstrates disc desiccation with degenerative endplate marrow change and 2 to 3 mm disc bulge. There is mild facet degeneration and ligament prominence. There is nominal dural impression including nominal inferior foraminal narrowing, without focal neural compression. L5-S1 demonstrates disc desiccation and slight narrowing with 3 to 4 mm right greater than left disc bulge. There is mild facet degeneration. There is moderate left and minimal right lateral recess stenosis with mild right and minimal left foraminal stenosis, without spinal stenosis. IMPRESSION: IMPRESSION: Mild nerve root enhancement as above suggesting neuritis. Mild multilevel degenerative disc, endplate and facet changes with generally mild degrees of neural comprise, moderate on the left at L5-S1. Electronically signed by: MD on 10/23/2023 5:01 PM Exam End: 10/23/23 16:17 Specimen Collected: 10/23/23 16:34 Last Resulted: 10/23/23 17:01 Received From: Facility Result Received: 12/05/23 12:44
Aktuelle Erkrankungen
Problem List Pure hypercholesterolemia Hypertension At risk for cardiovascular event Coronary artery disease involving native coronary artery without angina pectoris Hypogonadism male Folate deficiency Allergic rhinitis Elevated liver enzymes History of colon polyps History of Helicobacter pylori infection Dyspepsia and disorder of function of stomach Functional bloating IBS (irritable bowel syndrome) History of hepatitis B Colon polyps Hepatitis B (Resolved) Abnormal anal Papanicolaou smear Erythrocytosis Human immunodeficiency virus (HIV) disease History of chlamydia History of gonorrhea of rectum Acromioclavicular joint arthritis (Resolved) Asthma Epidermoid cyst of skin
Vorgeschichte
Problem List Pure hypercholesterolemia Hypertension At risk for cardiovascular event Coronary artery disease involving native coronary artery without angina pectoris Hypogonadism male Folate deficiency Allergic rhinitis Elevated liver enzymes History of colon polyps History of Helicobacter pylori infection Dyspepsia and disorder of function of stomach Functional bloating IBS (irritable bowel syndrome) History of hepatitis B Colon polyps Hepatitis B (Resolved) Abnormal anal Papanicolaou smear Erythrocytosis Human immunodeficiency virus (HIV) disease History of chlamydia History of gonorrhea of rectum Acromioclavicular joint arthritis (Resolved) Asthma Epidermoid cyst of skin
Andere Medikamente
albuterol 90 mcg/act inhaler azelastine 0.15% nasal spray azelastine 137 mcg/spray nasal spray fluticasone 50 mcg/act nasal spray folic acid 1 mg tablet rosuvastatin 20 mg tablet benazepril 40 mg tablet dolutegravir-lamiVUDine (DOVATO) 50-3
Allergien
Zidovudine: Nausea And Vomiting
Vorherige Impfungen
-

VAERS 2696985

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

schwer
Staat
AR
Alter
11,0
Geschlecht
F
Eingang
17.10.2023
Impfdatum
16.10.2023
Beginn
17.10.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Cold sweat Presyncope Seizure Somnolence

Symptomtext

After administering last immunization, Tdap, Meningococcal, HPV and Flu shot, approx. 1 minute later patient convulsed and made snorting noise lasting approx. 15sec. Grandmother states patients father does the same thing after injections. Grandmother states patient does not have history of seizures or family history. Patients skin cool and clammy and could not keep eyes open for 15 seconds. Patient aware of surroundings, but drowsy for 3 minutes. Normal respirations, pulse. Offered to call ambulance transfer to ED. Declined by grandmother. Advised grandmother to seek further medical attention if needed. Assisted patient to personal vehicle in wheel chair, Patient stable and alert when leaving health unit. Grandmother states she was taking patient to ED. 1600 TC from patient grandmother stating patient was seen in ER and released, ER stated patient had vasovagal reaction from immunizations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Presyncope
Hospital-Tage
-
Labordaten
Patient went to ER for futher medical assistance. Released from ER same day. ER stated patient had vasovagal reaction from immunizations.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2687032

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

schwer
Staat
RI
Alter
4,0
Geschlecht
M
Eingang
27.09.2023
Impfdatum
27.09.2023
Beginn
27.09.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Loss of consciousness Pallor Syncope

Symptomtext

Patient reported stomach hurt and subsequently had syncopal episode, witnessed by mom, sitting on mom's lap. Quickly regained consciousness. Pediatrician in to assess. Patient layed down, color returned, answering questions appropriately, vitals stable. Mom educated on ER precautions. Took patient home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported
Vorgeschichte
No health conditions
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2713175

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

moderat
Staat
CO
Alter
30,0
Geschlecht
F
Eingang
13.11.2023
Impfdatum
12.10.2023
Beginn
12.10.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injected limb mobility decreased Pain

Symptomtext

Right shoulder with decreased motion after receiving flu shot. History of chronic shoulder pain and history of steroid injections in the past. Pain with flexion and abduction

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
not applicable
Aktuelle Erkrankungen
mixed anxiety and depression, ADHD
Vorgeschichte
mixed anxiety and depression, ADHD
Andere Medikamente
none
Allergien
Flexeril
Vorherige Impfungen
-

VAERS 2723531

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

mild
Staat
GA
Alter
38,0
Geschlecht
F
Eingang
13.12.2023
Impfdatum
21.11.2023
Beginn
22.11.2023
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dry skin Injection site reaction Rash Rash pruritic

Symptomtext

Patient reports on 12/12/23 that she developed a rash that was very dry and itchy at injection site as well as on arms and legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site reaction
Hospital-Tage
-
Labordaten
Patient reports she sought medical care at local Urgent Care facility where she was given a cream for the rash. Pt is unaware of name of cream.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
N/A
Allergien
None
Vorherige Impfungen
-

VAERS 2683380

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

mild
Staat
NV
Alter
16,0
Geschlecht
M
Eingang
18.09.2023
Impfdatum
18.09.2023
Beginn
18.09.2023
Tage bis Beginn
0,0
Dosis
7+
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Balance disorder Blood glucose normal Blood pressure decreased Chest injury Dizziness Slow response to stimuli

Symptomtext

The father stated that the pt began feeling dizzy and looked like he was going to faint several minutes after receiving vaccinations. Upon leaving the exam room, the patient hit his chest on the doorframe and his father caught him to support him. No LOC. Father called to medical assistant, who had the patient sit down. The patient was examined by FNP and blood pressure and blood sugar were taken. Blood sugar reading was normal. Blood pressure readings were low. The patient was slow to respond to questions asked by FNP. Paramedics were called, and the patient was transported to Hospital.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
blood pressure 09/18/2023 - 71/35, 45 pulse (seated); 71/41, 55 pulse (standing) fingerstick 09/18/2023 - 83 non-fasting
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
CETIRIZE
Allergien
N/A
Vorherige Impfungen
-

VAERS 2711959

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
IN
Alter
2,0
Geschlecht
F
Eingang
09.11.2023
Impfdatum
08.11.2023
Beginn
08.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered Product preparation error

Symptomtext

While doing inventory, noticed this patient received entire vial of Pfizer COVID vaccine. Vial was suppose to be diluted and have 3 doses in each vial. It was not diluted and patient given 0.3ml, which was all 3 doses.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Sickle Cell Trait
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2709652

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
RI
Alter
-
Geschlecht
U
Eingang
03.11.2023
Impfdatum
21.10.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Fluarix was exposed to 31 Fahrenheit; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect product storage in a patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2023-2024 season) (batch number 554NM, expiry date 30-JUN-2024) for prophylaxis. On 21-OCT-2023, the patient received Fluarix Quadrivalent 2023-2024 season. On an unknown date, an unknown time after receiving Fluarix Quadrivalent 2023-2024 season, the patient experienced incorrect product storage (Verbatim: Fluarix was exposed to 31 Fahrenheit). The outcome of the incorrect product storage was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 25-OCT-2023 The reporter stated that Fluarix was exposed to 31 Fahrenheit and administered to at least 60 patients as they had a flu vaccine clinic which led to incorrect product storage. The reporter consented to follow up via postal. The vaccine administration facility was the same as primary reporter. The reporter did not have any patient demographics at the time of reporting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2702622

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
GA
Alter
4,0
Geschlecht
F
Eingang
26.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error

Symptomtext

During School Based Flu event, child was given flu vaccine when parent marked "I do not give consent", but signed the portion where it authorizes consent. It was not caught by clerical or nursing staff at time of clinic. System was verified prior to administering the dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2701559

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
CO
Alter
46,0
Geschlecht
M
Eingang
25.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered No adverse event

Symptomtext

No adverse event. Patient received two flu shots in one season.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Diabetes mellitus
Andere Medikamente
MetFormin, Omeprazole
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2695360

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
12.10.2023
Impfdatum
12.10.2023
Beginn
12.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Wrong product administered

Symptomtext

Vaccine clinic vaccinator administered Fluarix vaccine to client instead of COVID-19 Moderna vaccine. Client previously had flu vaccine 1 month ago. Consulted with Health Officer, and provided reassurance and information to client.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2692747

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 554NM

gering
Staat
NC
Alter
13,0
Geschlecht
F
Eingang
09.10.2023
Impfdatum
28.09.2023
Beginn
05.10.2023
Tage bis Beginn
7,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Skin lesion

Symptomtext

Shiny red lesions on right arm (multiple), stomach, and chin.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-